Diabetes and the Kidney
Caused by an epidemic increase in obesity and diabetes and metabolic syndromes, diabetic nephropathy has become a leading cause of end-stage renal disease in many developed countries. The publication at hand provides a concise overview of the current state of clinical and basic research in the field. It starts with a summary of the epidemiology and genetics of diabetic nephropathy in different ethnic groups, followed by a review of its clinical manifestation, the link with the metabolic syndrome and obesity, and the pathology of diabetic nephropathy. Building on this basis, the latest findings on pathogenetic, epigenetic and inflammatory mechanisms are presented. The publication also looks at advances in the areas of tubulopathy and the kallikrein-kinin system as well as at the latest animal models and the role of lipoproteins and proteomics. This is followed by a discussion of promising therapeutic approaches such as experimental anti-fibrotic strategies, stem cell therapy and pancreatic transplantation; expert reviews on the emerging entity of new onset diabetes after transplantation and the preventive strategies for diabetic nephropathy conclude the material presented. Written by a panel of leading international experts, this book is highly recommended for nephrologists, diabetologists, internist, transplant physicians, scientists, geneticists, epidemiologists and stem cell biologists working in the field of diabetic nephropathy.
Download citation file:
Digital Version
Print Version
Table of Contents
-
1 - 7: Epidemiology of Diabetic NephropathyByAnne T. Reutens;Anne T. ReutensSchool of Public Health and Preventive Medicine, Monash University, and Baker IDI Heart and Diabetes Institute, Melbourne, Vic, AustraliaSearch for other works by this author on:Robert C. AtkinsRobert C. AtkinsSchool of Public Health and Preventive Medicine, Monash University, and Baker IDI Heart and Diabetes Institute, Melbourne, Vic, AustraliaSearch for other works by this author on:
-
8 - 18: Genetics of Diabetic Nephropathy in Diverse Ethnic GroupsByCaroline Brorsson;Caroline BrorssonGlostrup Research Institute, Glostrup University Hospital, Glostrup, DenmarkSearch for other works by this author on:Flemming PociotFlemming PociotGlostrup Research Institute, Glostrup University Hospital, Glostrup, DenmarkSearch for other works by this author on:
-
19 - 27: Clinical Manifestation and Natural History of Diabetic NephropathyByEberhard Ritz;Eberhard RitzaDepartment of Nephrology, Heidelberg University, Heidelberg, Germany;Search for other works by this author on:Xiao-Xi Zeng;Xiao-Xi ZengbDepartment of Medicine, West China Hospital of Sichuan University, Chengdu, China;Search for other works by this author on:Ivan RychlíkIvan Rychlíkc2nd Department of Medicine, 3rd Faculty of Medicine, Charles University, Prague, Czech RepublicSearch for other works by this author on:
-
28 - 35: Obesity, Metabolic Syndrome and Diabetic NephropathyByChristine Maric;Christine MaricDepartment of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Miss., USASearch for other works by this author on:John E. HallJohn E. HallDepartment of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Miss., USASearch for other works by this author on:
-
36 - 47: Pathology of Human Diabetic NephropathyByBehzad Najafian;Behzad NajafianaDepartment of Pathology, University of Washington, Seattle, Wash., andSearch for other works by this author on:Charles E. Alpers;Charles E. AlpersaDepartment of Pathology, University of Washington, Seattle, Wash., andSearch for other works by this author on:Agnes B. FogoAgnes B. FogobDepartment of Pathology, Vanderbilt University Medical Center, Nashville, Tenn., USASearch for other works by this author on:
-
48 - 56: Pathogenesis and Progression of ProteinuriaByMerlin C. ThomasMerlin C. ThomasBaker IDI Heart and Diabetes Institute, Melbourne, Vic., AustraliaSearch for other works by this author on:
-
57 - 65: Epigenetic MechanismsByLouisa M. Villeneuve;Louisa M. VilleneuveDivision of Cellular and Molecular Diabetes Research, Department of Diabetes, Beckman Research Institute of City of Hope, Duarte, Calif, USASearch for other works by this author on:Rama NatarajanRama NatarajanDivision of Cellular and Molecular Diabetes Research, Department of Diabetes, Beckman Research Institute of City of Hope, Duarte, Calif, USASearch for other works by this author on:
-
66 - 74: Advanced Glycation End ProductsByMerlin C. ThomasMerlin C. ThomasBaker IDI Heart and Diabetes Institute, Melbourne, Vic., AustraliaSearch for other works by this author on:
-
75 - 82: Transforming Growth Factor-β and SmadsByHui Yao Lan;Hui Yao LanDepartment of Medicine and Therapeutics, and Li Ka Shing Institute of Health Sciences, the Chinese University of Hong Kong, Hong Kong SAR, ChinaSearch for other works by this author on:Arthur C.K. ChungArthur C.K. ChungDepartment of Medicine and Therapeutics, and Li Ka Shing Institute of Health Sciences, the Chinese University of Hong Kong, Hong Kong SAR, ChinaSearch for other works by this author on:
-
83 - 92: Angiogenic FactorsByCharbel C. Khoury;Charbel C. KhouryaFeinberg School of Medicine, Northwestern University, Chicago, Ill., USA;Search for other works by this author on:Fuad N. ZiyadehFuad N. ZiyadehbDepartments of Internal Medicine and Biochemistry, Faculty of Medicine, American University of Beirut, Beirut, LebanonSearch for other works by this author on:
-
93 - 101: Endothelial Nitric Oxide SynthaseByTakahiko Nakagawa;Takahiko NakagawaDivision of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, Colo., USASearch for other works by this author on:Richard J. JohnsonRichard J. JohnsonDivision of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, Colo., USASearch for other works by this author on:
-
102 - 112: Reactive Oxygen Species and Oxidative StressByHyunjin Noh;Hyunjin NohaHyonam Kidney Laboratory, Division of Nephrology, Department of Internal Medicine, Soon Chun Hyang University, andSearch for other works by this author on:Hunjoo HaHunjoo HabDivision of Life and Pharmaceutical Sciences, Department of Bioinspired Science, College of Pharmacy, Ewha Womans University, Seoul, South KoreaSearch for other works by this author on:
-
113 - 123: Inflammatory PathwaysByJuan F. Navarro-González;Juan F. Navarro-GonzálezaNephrology Service andbResearch Unit, University Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, SpainSearch for other works by this author on:Carmen Mora-FernándezCarmen Mora-FernándezbResearch Unit, University Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, SpainSearch for other works by this author on:
-
124 - 134: Diabetic Tubulopathy: An Emerging EntityBySydney C.W. Tang;Sydney C.W. TangDepartment of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong SAR, ChinaSearch for other works by this author on:Joseph C.K. Leung;Joseph C.K. LeungDepartment of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong SAR, ChinaSearch for other works by this author on:Kar Neng LaiKar Neng LaiDepartment of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong SAR, ChinaSearch for other works by this author on:
-
135 - 144: The Renin-Angiotensin SystemByKar Neng Lai;Kar Neng LaiDepartment of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong SAR, ChinaSearch for other works by this author on:Joseph C.K. Leung;Joseph C.K. LeungDepartment of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong SAR, ChinaSearch for other works by this author on:Sydney C.W. TangSydney C.W. TangDepartment of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong SAR, ChinaSearch for other works by this author on:
-
145 - 155: The Kallikrein-Kinin SystemBySydney CW. Tang;Sydney CW. TangDepartment of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong SAR, ChinaSearch for other works by this author on:Joseph C.K. Leung;Joseph C.K. LeungDepartment of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong SAR, ChinaSearch for other works by this author on:Kar Neng LaiKar Neng LaiDepartment of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong SAR, ChinaSearch for other works by this author on:
-
156 - 164: Translating Experimental Diabetic Nephropathy Studies from Mice to MenByMatthew D. BreyerMatthew D. BreyerLead Generation Biology, Biotechnology Discovery Research, Lilly Research Laboratories, Indianapolis, Ind., USASearch for other works by this author on:
-
165 - 171: Role of Triglyceride-Rich Lipoproteins in Renal InjuryByKit Fai Ng;Kit Fai NgDivision of Cardiovascular Medicine, University of California Davis School of Medicine, Davis, Calif., USASearch for other works by this author on:Hnin Hnin Aung;Hnin Hnin AungDivision of Cardiovascular Medicine, University of California Davis School of Medicine, Davis, Calif., USASearch for other works by this author on:John C. RutledgeJohn C. RutledgeDivision of Cardiovascular Medicine, University of California Davis School of Medicine, Davis, Calif., USASearch for other works by this author on:
-
172 - 183: Study of Diabetic Nephropathy in the Proteomic EraByVisith ThongboonkerdVisith ThongboonkerdMedical Proteomics Unit, Office for Research and Development, Faculty of Medicine Siriraj Hospital, and Center for Research in Complex Systems Science, Mahidol University, Bangkok, ThailandSearch for other works by this author on:
-
184 - 195: Treatment and Landmark Clinical Trials for RenoprotectionByRose Z.W. Ting;Rose Z.W. TingaDepartment of Medicine and Therapeutics, andSearch for other works by this author on:Andrea O.Y. Luk;Andrea O.Y. LukaDepartment of Medicine and Therapeutics, andSearch for other works by this author on:Juliana C.N. ChanJuliana C.N. ChanaDepartment of Medicine and Therapeutics, andbHong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, The Prince of Wales Hospital, Hong Kong SAR, ChinaSearch for other works by this author on:
-
196 - 208: Intensive Glycemic Control and Renal OutcomeByMin Jun;Min JunRenal and Metabolic Division, The George Institute for Global Health, Sydney Medical School, University of Sydney, Camperdown, N.S.W., AustraliaSearch for other works by this author on:Vlado Perkovic;Vlado PerkovicRenal and Metabolic Division, The George Institute for Global Health, Sydney Medical School, University of Sydney, Camperdown, N.S.W., AustraliaSearch for other works by this author on:Alan CassAlan CassRenal and Metabolic Division, The George Institute for Global Health, Sydney Medical School, University of Sydney, Camperdown, N.S.W., AustraliaSearch for other works by this author on:
-
209 - 216: Nuclear Hormone Receptors as Therapeutic TargetsByMoshe Levi;Moshe LeviaDivision of Renal Diseases and Hypertension, Department of Medicine, University of Colorado Denver, Aurora, Colo., andSearch for other works by this author on:Xiaoxin Wang;Xiaoxin WangaDivision of Renal Diseases and Hypertension, Department of Medicine, University of Colorado Denver, Aurora, Colo., andSearch for other works by this author on:Devasmita ChoudhuryDevasmita ChoudhurybDivision of Nephrology, Department of Medicine, University of Texas Southwestern Medical Center Dallas and VA Medical Center, Dallas, Tex., USASearch for other works by this author on:
-
217 - 227: Antifibrotic Treatment and Other New Strategies for Improving Renal OutcomesByAnna Mathew;Anna MathewaCenter for Renal Translational Medicine, Division of Nephrology-Hypertension, Department of Medicine, University of California San Diego andbVeterans Affairs San Diego Healthcare System, Veterans Medical Research Foundation, San Diego, Calif, USASearch for other works by this author on:Robyn Cunard;Robyn CunardaCenter for Renal Translational Medicine, Division of Nephrology-Hypertension, Department of Medicine, University of California San Diego andbVeterans Affairs San Diego Healthcare System, Veterans Medical Research Foundation, San Diego, Calif, USASearch for other works by this author on:Kumar SharmaKumar SharmaaCenter for Renal Translational Medicine, Division of Nephrology-Hypertension, Department of Medicine, University of California San Diego andbVeterans Affairs San Diego Healthcare System, Veterans Medical Research Foundation, San Diego, Calif, USASearch for other works by this author on:
-
228 - 236: Kidney Regeneration: Any Prospects?ByPaola RomagnaniPaola RomagnaniExcellence Centre for Research, Transfer and High Education for the Development of de novo Therapies, and Meyer Children’s Hospital, Nephrology Unit, Department of Clinical Pathophysiology, University of Florence, Florence, ItalySearch for other works by this author on:
-
237 - 246: Effects of Pancreas Transplantation on the Prevention and Reversal of Diabetic NephropathyByPaola Fioretto;Paola FiorettoaDepartment of Medical and Surgical Sciences, University of Padova Medical School, Padova, Italy;Search for other works by this author on:Michael MauerMichael MauerbDepartments of Pediatrics and Medicine, University of Minnesota Medical School, Minneapolis, Minn., USASearch for other works by this author on:
-
247 - 255: New-Onset Diabetes and Nephropathy after Renal TransplantationByJoelle Guitard;Joelle GuitardaDepartment of Nephrology, Dialysis, and Organ Transplantation, CHU Rangueil, andSearch for other works by this author on:Lionel Rostaing;Lionel RostaingaDepartment of Nephrology, Dialysis, and Organ Transplantation, CHU Rangueil, andbINSERM U563, IFR-BMT, CHU Purpan, Toulouse, FranceSearch for other works by this author on:Nassim KamarNassim KamaraDepartment of Nephrology, Dialysis, and Organ Transplantation, CHU Rangueil, andbINSERM U563, IFR-BMT, CHU Purpan, Toulouse, FranceSearch for other works by this author on:
-
256 - 263: Into the Future: Prevention of DiabetesByYolanda E. Bogaert;Yolanda E. BogaertDepartment of Medicine, University of Colorado School of Medicine, Denver, Aurora, Colo., USASearch for other works by this author on:Robert W. SchrierRobert W. SchrierDepartment of Medicine, University of Colorado School of Medicine, Denver, Aurora, Colo., USASearch for other works by this author on: